Showing 1 - 20 results of 24 for search '"СЕРДЕЧНО-СОСУДИСТАЯ ЗАБОЛЕВАЕМОСТЬ"', query time: 0.64s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
    Academic Journal

    Source: Rational Pharmacotherapy in Cardiology; Vol 12, No 2 (2016); 186-190 ; Рациональная Фармакотерапия в Кардиологии; Vol 12, No 2 (2016); 186-190 ; 2225-3653 ; 1819-6446 ; 10.20996/1819-6446-2016-12-2

    File Description: application/pdf

    Relation: https://www.rpcardio.com/jour/article/view/1237/1267; Zinman B, Wanner C, Lachin JM, et al., EMPA REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015;373:2117-28.; Fitchett D, Zinman B, Wanner C, et al. Heart failure outcomes with empagliflozin in patients with type; diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME® trial. Eur Heart J. 2016 Jan 26. [Epub ahead of print]; https://www.rpcardio.com/jour/article/view/1237

  6. 6
  7. 7
    Academic Journal

    File Description: text/html

  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20